Carbios' China Play: A Calculated Bet on Licensing to Scale Biorecycling

CLERMONT-FERRAND, France – June 22, 2026 – A routine Annual General Meeting has signaled a pivotal shift for Carbios. While the overwhelming approval of all resolutions by its shareholders provides a strong vote of confidence, the real headline is the formalization of a joint venture in China. This move transitions the French biotech firm’s groundbreaking enzymatic recycling technology from a promising pilot to a full-scale industrial reality in the world’s largest plastics market. The new venture, Kaibio Biotechnology, formed with PET giant Wankai New Materials, is not merely another plant; it is the first real-world test of Carbios' ambitious, asset-light licensing strategy, a model designed for rapid global deployment.

For years, Carbios has been a celebrated name in the world of sustainable innovation, developing enzymes that can break down PET plastic into its original building blocks, ready to be remade into virgin-quality material. But the journey from a successful lab demonstration to industrial relevance is a treacherous one that has humbled many tech pioneers. The Kaibio joint venture represents Carbios’ definitive step into that unforgiving arena, a move that will be scrutinized by investors, partners, and competitors alike.

The Anatomy of a High-Stakes Partnership

The structure of the Kaibio venture reveals a carefully engineered plan focused on execution and de-risking. Carbios is not going it alone. Its partner, Wankai New Materials, is the third-largest PET producer in China and a subsidiary of the formidable Zhink Group. This is not a speculative partnership; it is an alliance with an industry leviathan that possesses the operational muscle, market access, and regional expertise Carbios lacks.

The deal sees Wankai taking a 70% majority stake in the joint venture, with Carbios holding the remaining 30%. The planned facility in Haining, Zhejiang province, will be built on a Wankai-owned site already equipped with essential infrastructure, a move expected to significantly reduce initial investment costs. With an estimated price tag of €115 million, the plant will be financed primarily through 70% debt, which Wankai has agreed to guarantee in its entirety. This financial backing from a major industrial player is a powerful endorsement of the technology's commercial viability.

Once operational, a target set for the first quarter of 2027, the plant is designed to process 50,000 tons of PET waste annually. This is a significant scale, moving far beyond the capacity of Carbios’ existing demonstration plant and providing the first true measure of the technology's performance and economics in a continuous, high-volume industrial setting. The choice of China is equally strategic, targeting a market that generated 60 million tonnes of plastic waste in 2020 but recycled just over a quarter of it, creating immense pressure and opportunity for advanced solutions.

A Licensing Blueprint for Global Scale

Perhaps more significant than the plant itself is the business model it validates. Carbios is pursuing a licensing strategy, positioning itself as a technology provider rather than a global plant operator. Under the agreement, Carbios grants Kaibio the right to use its patented PET depolymerization technology while retaining full ownership of the intellectual property. This approach allows for rapid scaling without the colossal capital expenditure and operational burden of building and running a global network of wholly-owned facilities.

As Isabelle Parize, Chairwoman of the Board of Directors of Carbios, stated, “This technological leadership enables us to roll out our licensing model, starting with Wankai in China and expanding soon to other geographical areas, to drive long-term value for Carbios and its shareholders.”

The terms of the agreement with Wankai underscore this ambition. Carbios has granted its partner exclusive rights to its technology in Asia for an initial three-year period, a commitment contingent on Wankai licensing at least 100,000 tons per year of additional capacity. This structure incentivizes the majority partner to become a champion for the technology, driving expansion across a continent hungry for circular economy solutions. The long-term vision shared by the partners is to deploy several plants across Asia, potentially reaching a capacity of one million tonnes per year.

This model effectively transforms Carbios from a pure R&D entity into an industrial enabler, leveraging the capital and infrastructure of established industry players to embed its technology into the existing value chain. Its success in China will serve as a powerful blueprint for future partnerships in North America and Europe, where regulatory pressure and consumer demand for recycled content are creating fertile ground for growth.

The Technology's Industrial Crucible

At the heart of this strategy is the technology itself. Enzymatic recycling promises what mechanical recycling cannot: the infinite circularity of plastic without quality degradation. By using a custom-engineered enzyme to break down PET, Carbios can produce monomers that are indistinguishable from those derived from fossil fuels. This allows for the creation of new food-grade packaging and high-performance textiles from 100% recycled content—a holy grail for consumer brands committed to sustainability goals.

Furthermore, the process operates at mild temperatures, offering a significant environmental advantage. Life-cycle assessments suggest it could cut carbon emissions by over 50% compared to producing virgin plastic. It can also handle complex waste streams, like colored bottles and polyester textiles, that are challenging for traditional mechanical recycling systems.

However, the technology is not without its challenges, which have historically revolved around the speed of the enzymatic reaction and the overall cost-effectiveness compared to virgin production. Carbios has made significant strides, reporting that its latest enzyme can depolymerize 90% of PET in just 10 hours. The Kaibio plant is the ultimate industrial crucible where these metrics will be tested and proven. Its operational data on energy consumption, yield, and purity will determine the economic competitiveness of the process and, by extension, the pace of its global adoption.

Governance as the Bedrock for Growth

The strong shareholder mandate, with over 87% of votes approving all resolutions at the AGM, is a clear endorsement of this strategic pivot toward industrialization. This is not simply a rubber-stamping exercise but a reflection of investor confidence in the management and board's ability to execute a complex, capital-intensive global strategy.

This confidence is bolstered by the composition of Carbios' Board of Directors. The eight-member board includes four independent directors with deep expertise spanning critical domains: academia and green chemistry, industrial operations in the polymer sector, international finance and investment banking, and the commercialization of renewable technologies. This diversity provides the robust governance and strategic oversight necessary to navigate the challenges of scaling a disruptive technology on the world stage.

As Carbios restarts construction on its first commercial plant in Longlaville, France, and breaks ground in China, it is clear the company has moved beyond the realm of pure innovation. It is now firmly in the business of execution. The Kaibio venture is the first and most important chapter in this new story, and its success or failure will be a bellwether not just for Carbios, but for the future of the entire advanced recycling industry.